Publications by authors named "Carol D Weiss"

Claim this Profile
C
Capture of fusion-intermediate conformations of SARS-CoV-2 spike requires receptor binding and cleavage at either the S1/S2 or S2' site.
Sabrina Lusvarghi, Russell Vassell, Brittany Williams, Haseebullah Baha, Sabari Nath Neerukonda, Carol D Weiss

PLoS Pathog· April 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Characterization of spike S1/S2 processing and entry pathways of lentiviral pseudoviruses bearing seasonal human coronaviruses NL63, 229E, and HKU1 spikes.
Sabari Nath Neerukonda, Russell Vassell, Sabrina Lusvarghi, Shufeng Liu, Adovi Akue, Carol D Weiss

Microbiol Spectr· March 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Comparison of neuraminidase inhibiting antibody responses elicited by egg- and cell-derived influenza vaccines.
Esmeralda Alvarado-Facundo, Rachel Herrup, Wei Wang, Rhonda E Colombo, Limone Collins, Carol D Weiss

Vaccine· February 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Automated and virus variant-programmable surrogate test qualitatively compares to the gold standard SARS-CoV-2 neutralization assay.
Danielle W Ali, Maggie L Bartlett, Christopher D Heger, Francisco Ramirez, Linwood Johnson, Carol D Weiss

Npj Viruses· December 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Human and hamster sera correlate well in identifying antigenic drift among SARS-CoV-2 variants, including JN.1.
Wei Wang, Gitanjali Bhushan, Stephanie Paz, Charles B Stauft, Prabhuanand Selvaraj, Carol D Weiss

J Virol· November 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Comparative analysis of SARS-CoV-2 neutralization titers reveals consistency between human and animal model serum and across assays.
Barbara Mühlemann, Samuel H Wilks, Lauren Baracco, Meriem Bekliz, Juan Manuel Carreño, Carol D Weiss

Sci Transl Med· May 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Immune and behavioral correlates of protection against symptomatic post-vaccination SARS-CoV-2 infection.
Emilie Goguet, Cara H Olsen, William A Meyer, Sara Ansari, John H Powers, Carol D Weiss

Front Immunol· April 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Antigenic cartography using hamster sera identifies SARS-CoV-2 JN.1 evasion seen in human XBB.1.5 booster sera.
Wei Wang, Gitanjali L Bhushan, Stephanie Paz, Charles B Stauft, Prabhu Selvaraj, Carol D Weiss

bioRxiv· April 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Effects of N-glycan modifications on spike expression, virus infectivity, and neutralization sensitivity in ancestral compared to Omicron SARS-CoV-2 variants.
Sabrina Lusvarghi, Charles B Stauft, Russell Vassell, Brittany Williams, Haseebullah Baha, Carol D Weiss

PLoS Pathog· November 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Comparative Analysis of SARS-CoV-2 Antigenicity across Assays and in Human and Animal Model Sera.
Barbara Mühlemann, Samuel H Wilks, Lauren Baracco, Meriem Bekliz, Juan Manuel Carreño, Carol D Weiss

bioRxiv· September 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Bivalent Coronavirus Disease 2019 Vaccine Antibody Responses to Omicron Variants Suggest That Responses to Divergent Variants Would Be Improved With Matched Vaccine Antigens.
Wei Wang, Emilie Goguet, Stephanie Paz, Russell Vassell, Simon Pollett, Carol D Weiss

J Infect Dis· August 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Neutralizing and protective murine monoclonal antibodies to the hemagglutinin of influenza H5 clades 2.3.2.1 and 2.3.4.4.
Carlotta Schuele, Falko Schmeisser, Megan Orr, Clement A Meseda, Anupama Vasudevan, Carol D Weiss

Influenza Other Respir Viruses· May 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
An external quality assessment feasibility study; cross laboratory comparison of haemagglutination inhibition assay and microneutralization assay performance for seasonal influenza serology testing: A FLUCOP study.
Joanna Waldock, Carol D Weiss, Wei Wang, Min Z Levine, Stacie N Jefferson

Front Immunol· March 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The trispecific DARPin ensovibep inhibits diverse SARS-CoV-2 variants.
Sylvia Rothenberger, Daniel L Hurdiss, Marcel Walser, Francesca Malvezzi, Jennifer Mayor, Carol D Weiss

Nat Biotechnol· December 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Antigenic cartography of well-characterized human sera shows SARS-CoV-2 neutralization differences based on infection and vaccination history.
Wei Wang, Sabrina Lusvarghi, Rahul Subramanian, Nusrat J Epsi, Richard Wang, Carol D Weiss

Cell Host Microbe· December 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Characterization of Entry Pathways, Species-Specific Angiotensin-Converting Enzyme 2 Residues Determining Entry, and Antibody Neutralization Evasion of Omicron BA.1, BA.1.1, BA.2, and BA.3 Variants.
Sabari Nath Neerukonda, Richard Wang, Russell Vassell, Haseebullah Baha, Sabrina Lusvarghi, Carol D Weiss

J Virol· September 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Defining the risk of SARS-CoV-2 variants on immune protection.
Marciela M DeGrace, Elodie Ghedin, Matthew B Frieman, Florian Krammer, Alba Grifoni, Carol D Weiss

Nature· May 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
SARS-CoV-2 BA.1 variant is neutralized by vaccine booster-elicited serum but evades most convalescent serum and therapeutic antibodies.
Sabrina Lusvarghi, Simon D Pollett, Sabari Nath Neerukonda, Wei Wang, Richard Wang, Carol D Weiss

Sci Transl Med· May 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Measuring Neutralizing Antibodies to SARS-CoV-2 Using Lentiviral Spike-Pseudoviruses.
Sabari Nath Neerukonda, Russell Vassell, Carol D Weiss, Wei Wang

Methods Mol Biol· May 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Durability of Antibody Response and Frequency of SARS-CoV-2 Infection 6 Months after COVID-19 Vaccination in Healthcare Workers.
Eric D Laing, Carol D Weiss, Emily C Samuels, Si'Ana A Coggins, Wei Wang

Emerg Infect Dis· April 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
D-dimer and CoV-2 spike-immune complexes contribute to the production of PGE2 and proinflammatory cytokines in monocytes.
Yun-Jong Park, David Acosta, Russell Vassell, Juanjie Tang, Surender Khurana, Carol D Weiss

PLoS Pathog· April 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
K
Key Substitutions in the Spike Protein of SARS-CoV-2 Variants Can Predict Resistance to Monoclonal Antibodies, but Other Substitutions Can Modify the Effects.
Sabrina Lusvarghi, Wei Wang, Rachel Herrup, Sabari Nath Neerukonda, Russell Vassell, Carol D Weiss

J Virol· January 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
SARS-CoV-2 Delta Variant Displays Moderate Resistance to Neutralizing Antibodies and Spike Protein Properties of Higher Soluble ACE2 Sensitivity, Enhanced Cleavage and Fusogenic Activity.
Sabari Nath Neerukonda, Russell Vassell, Sabrina Lusvarghi, Richard Wang, Fernando Echegaray, Carol D Weiss

Viruses· December 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
SARS-CoV-2 Omicron neutralization by therapeutic antibodies, convalescent sera, and post-mRNA vaccine booster.
Sabrina Lusvarghi, Simon D Pollett, Sabari Nath Neerukonda, Wei Wang, Richard Wang, Carol D Weiss

bioRxiv· December 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
SARS-COV-2 Delta variant displays moderate resistance to neutralizing antibodies and spike protein properties of higher soluble ACE2 sensitivity, enhanced cleavage and fusogenic activity.
Sabari Nath Neerukonda, Russell Vassell, Sabrina Lusvarghi, Richard Wang, Fernando Echegaray, Carol D Weiss

bioRxiv· November 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis